首页> 外文期刊>BMC Nephrology >Post renal transplant anemia: severity, causes and their association with graft and patient survival
【24h】

Post renal transplant anemia: severity, causes and their association with graft and patient survival

机译:肾移植后贫血:严重程度,病因及其与移植物和患者存活率的关系

获取原文
           

摘要

Post transplantation anemia (PTA) is common among kidney transplant patients. PTA is associated with increased graft loss and in most studies with increased mortality. However, the effect of the severity of anemia on this associations was not thoroughly evaluated. Patients who underwent kidney transplantation in Rabin Medical Center (RMC) were included in the study. Data were collected during the years 2002–2016. Anemia was defined as hemoglobin (Hb) level less than 12?g/dL in women and less than 13?g/dL in men, in accordance with World Health Organization (WHO) criteria. Severe anemia was defined as hemoglobin lower than 11?g/dL. Primary outcome was a composite of patient and graft survival. We used univariate and multivariate models to evaluate association between severity and specific causes of anemia with the outcomes. As the risk associated with anemia changed over time we analyzed the risk separately for the early and the late period (before and after 1251?days). Our cohort included 1139 patients, 412 (36.2%) of which had PTA and 134 (11.7%) had severe anemia. On multivariable analysis, severe anemia was highly associated with the primary outcome at the early period (HR 6.26, 95% CI 3.74–10.5, p??0.001). Anemia due to either AKI & acute rejection (11.9% of patients) or infection (16.7%), were associated with primary outcome at the early period (HR 9.32, 95% CI 5.3–26.41, p??0.001 and HR 3.99, 95% CI 2.01–7.95, p??0.001, respectively). There was non-significant trend for association between anemia due to Nutritional deficiencies (29.1%) and this outcome (HR 3.07, 95% CI 0.93–10.17, p?=?0.067). PTA is associated with graft loss and mortality especially during the first three years. Anemia severity affects this association. An anemia workup is recommended for PTA.
机译:移植后贫血(PTA)在肾移植患者中很常见。 PTA与移植物损失增加有关,在大多数研究中与死亡率增加有关。但是,贫血严重程度对该协会的影响尚未得到彻底评估。该研究包括在拉宾医学中心(RMC)接受肾脏移植的患者。在2002-2016年期间收集了数据。贫血的定义是根据世界卫生组织(WHO)的标准,女性的血红蛋白(Hb)水平低于12µg / dL,男性的血红蛋白(Hb)水平低于13µg / dL。严重贫血的定义是血红蛋白低于11微克/分升。主要结果是患者和移植物生存的综合。我们使用单变量和多变量模型来评估贫血的严重程度和特定原因与结果之间的关联。由于与贫血相关的风险随时间而变化,我们分别分析了早期和晚期(1251天之前和之后)的风险。我们的队列包括1139名患者,其中412名(36.2%)患有PTA,134名(11.7%)患有严重贫血。在多变量分析中,严重的贫血与早期的主要结局密切相关(HR 6.26,95%CI 3.74-10.5,p <0.001)。由AKI和急性排斥反应引起的贫血(占患者的11.9%)或感染(占16.7%)与早期的主要结局相关(HR 9.32,95%CI 5.3–26.41,p <0.001,HR 3.99, 95%CI 2.01-7.95,p <0.001。营养缺乏性贫血(29.1%)与该结果之间的关联性没有显着趋势(HR 3.07,95%CI 0.93-10.17,p?=?0.067)。 PTA与移植物的丢失和死亡率有关,尤其是在头三年。贫血严重程度会影响这种关联。建议对PTA进行贫血检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号